Gujarat Kidney & Super Speciality Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 16,500,000 (75%) | — | ₹18,810 Cr |
| NII (HNI) | — | 3,300,000 (15%) | — | ₹3,762 Cr |
| Retail | — | 2,200,000 (10%) | — | ₹2,508 Cr |
| Σ Total | — | 22,000,000 (100%) | — | ₹250,800 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹189,696 |
| S-HNI (Min) | 14 | 1,792 | ₹204,288 |
| B-HNI (Min) | 67 | 8,576 | ₹977,664 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 15 | 40 | 5 |
| EBITDA | 9 | 17 | 2 |
| Profit After Tax | 5 | 10 | 2 |
| Net Worth | 31 | 26 | 11 |
| Total Assets | 62 | 55 | 21 |
| Reserves & Surplus | 19 | 15 | 11 |
| Total Borrowing | 4 | 4 | 2 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Proposed acquisition of Parekhs Hospital at Ahmedabad. – 77.00
- Part-payment of purchase consideration for the already acquired “Ashwini Medical Centre”. – 12.40
- Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara. – 30.10
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location. – 6.83
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company – 1.20
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. –
- Acquisition of additional shareholding in the subsidiary namely “Harmony Medicare Private Limited” at Bharuch – 10.78
Company Overview
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) specializes in providing multispeciality healthcare services, including secondary and tertiary care, across multiple locations in Gujarat, India.
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
Services:
- Secondary Care Services: General and surgical treatments.
- Tertiary Care Services: Super speciality surgical procedures.
Gujarat Superspeciality Hospital provides medical care in areas such as internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology.
As of June 30, 2025, the company had 89 Doctors, 332 nurses and 338 other staff.
Competitive Strengths:
- Pre-eminence in renal sciences, with established sub-superspecialities in urology
- Asset light business model with focus in central region of Gujarat
- Ability to attract, retain skilled and experienced quality medical professionals
- Track record of operating and financial performance and growth